{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:35:02Z","timestamp":1778654102753,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tranon.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T03:56:20Z","timestamp":1553572580000},"page":"788-799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein"],"prefix":"10.1016","volume":"12","author":[{"given":"Shing","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwan","family":"Man","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Godfrey Chi-Fung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2019.02.003_bb0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/mutage\/geq004","article-title":"The impact of quercetin on cisplatin-induced clastogenesis and apoptosis in murine marrow cells","volume":"25","author":"Attia","year":"2010","journal-title":"Mutagenesis"},{"issue":"1","key":"10.1016\/j.tranon.2019.02.003_bb0010","first-page":"1","article-title":"Cisplatin nephrotoxicity: experimental and clinical studies","volume":"37","author":"Daugaard","year":"1990","journal-title":"Dan Med Bull"},{"issue":"4 Pt 2","key":"10.1016\/j.tranon.2019.02.003_bb0015","first-page":"1","article-title":"Cisplatin-induced ototoxicity: the effect of pigmentation and inhibitory agents","volume":"103","author":"Schweitzer","year":"1993","journal-title":"Laryngoscope"},{"issue":"Suppl 1","key":"10.1016\/j.tranon.2019.02.003_bb0020","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000227642","article-title":"Optimal control of acute cisplatin-induced emesis","volume":"53","author":"Verweij","year":"1996","journal-title":"Oncology"},{"issue":"3","key":"10.1016\/j.tranon.2019.02.003_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2307\/3579607","article-title":"Sensitivity to radiation treatment and changes in metallothionein synthesis in a transplanted murine tumor","volume":"148","author":"Shibuya","year":"1997","journal-title":"Radiat Res"},{"issue":"5","key":"10.1016\/j.tranon.2019.02.003_bb0030","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0272-6386(86)80112-3","article-title":"Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity","volume":"8","author":"Ries","year":"1986","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.tranon.2019.02.003_bb0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00280-007-0459-y","article-title":"Hydroxyl radical scavenger ameliorates cisplatin-induced nephrotoxicity by preventing oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria","volume":"61","author":"Santos","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.tranon.2019.02.003_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/1534735405282842","article-title":"Commentary: the pharmacological antioxidant amifostine -- implications of recent research for integrative cancer care","volume":"4","author":"Block","year":"2005","journal-title":"Integr Cancer Ther"},{"issue":"6 Suppl 18","key":"10.1016\/j.tranon.2019.02.003_bb0045","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.seminoncol.2003.11.014","article-title":"Amifostine: is there evidence of tumor protection?","volume":"30","author":"Koukourakis","year":"2003","journal-title":"Semin Oncol"},{"issue":"41","key":"10.1016\/j.tranon.2019.02.003_bb0050","doi-asserted-by":"crossref","first-page":"29094","DOI":"10.1074\/jbc.274.41.29094","article-title":"Interactions of bismuth complexes with metallothionein(II)","volume":"274","author":"Sun","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.tranon.2019.02.003_bb0055","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/ijms13033145","article-title":"Glutathione is a key player in metal-induced oxidative stress defenses","volume":"13","author":"Jozefczak","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"3-4","key":"10.1016\/j.tranon.2019.02.003_bb0060","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0162-0134(01)00347-6","article-title":"Advances in the structure and chemistry of metallothioneins","volume":"88","author":"Romero-Isart","year":"2002","journal-title":"J Inorg Biochem"},{"issue":"3","key":"10.1016\/j.tranon.2019.02.003_bb0065","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.taap.2009.03.026","article-title":"Metallothionein protection of cadmium toxicity","volume":"238","author":"Klaassen","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"10.1016\/j.tranon.2019.02.003_bb0070","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/iub.182","article-title":"Metalation of metallothioneins","volume":"61","author":"Ngu","year":"2009","journal-title":"IUBMB Life"},{"issue":"1","key":"10.1016\/j.tranon.2019.02.003_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1620\/tjem.196.9","article-title":"Recent studies on metallothionein: protection against toxicity of heavy metals and oxygen free radicals","volume":"196","author":"Sato","year":"2002","journal-title":"Tohoku J Exp Med"},{"issue":"10","key":"10.1016\/j.tranon.2019.02.003_bb0080","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1248\/bpb.29.2016","article-title":"Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors","volume":"29","author":"Futakawa","year":"2006","journal-title":"Biol Pharm Bull"},{"issue":"8","key":"10.1016\/j.tranon.2019.02.003_bb0085","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0006-2952(03)00504-5","article-title":"The changing faces of glutathione, a cellular protagonist","volume":"66","author":"Pompella","year":"2003","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.tranon.2019.02.003_bb0090","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1008211226339","article-title":"Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a double-blind, randomised trial","volume":"8","author":"Smyth","year":"1997","journal-title":"Ann Oncol"},{"issue":"1-2","key":"10.1016\/j.tranon.2019.02.003_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cbpa.2012.01.006","article-title":"Recent advances in bioinorganic chemistry of bismuth","volume":"16","author":"Li","year":"2012","journal-title":"Curr Opin Chem Biol"},{"issue":"6","key":"10.1016\/j.tranon.2019.02.003_bb0100","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1039\/C7SC00766C","article-title":"Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori","volume":"8","author":"Wang","year":"2017","journal-title":"Chem Sci"},{"issue":"92","key":"10.1016\/j.tranon.2019.02.003_bb0105","doi-asserted-by":"crossref","first-page":"16479","DOI":"10.1039\/C5CC04958J","article-title":"Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography","volume":"51","author":"Wang","year":"2015","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.tranon.2019.02.003_bb0110","first-page":"333","article-title":"Bismuth in medicine","volume":"41","author":"Sun","year":"2004","journal-title":"Met Ions Biol Syst"},{"key":"10.1016\/j.tranon.2019.02.003_bb0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinorgbio.2014.09.010","article-title":"Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET","volume":"142","author":"Chang","year":"2015","journal-title":"J Inorg Biochem"},{"issue":"1","key":"10.1016\/j.tranon.2019.02.003_bb0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41467-018-02828-6","article-title":"Bismuth antimicrobial drugs serve as broad-spectrum metallo-beta-lactamase inhibitors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.tranon.2019.02.003_bb0125","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1021\/bi00423a001","article-title":"Biochemistry of metallothionein","volume":"27","author":"Kagi","year":"1988","journal-title":"Biochemistry"},{"issue":"10","key":"10.1016\/j.tranon.2019.02.003_bb0130","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1248\/bpb.28.1859","article-title":"Induction of hepatic metallothionein by trivalent cerium: role of interleukin 6","volume":"28","author":"Kobayashi","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.tranon.2019.02.003_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01666038","article-title":"A simple quantitative procedure using monolayer cultures for cytotoxicity assays","volume":"9","author":"Borenfreund","year":"1984","journal-title":"J Tissue Cult Methods"},{"issue":"2","key":"10.1016\/j.tranon.2019.02.003_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/01.RES.82.2.166","article-title":"Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia\/reperfusion-induced cardiomyocyte apoptosis by carvedilol","volume":"82","author":"Yue","year":"1998","journal-title":"Circ Res"},{"issue":"1-2","key":"10.1016\/j.tranon.2019.02.003_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0162-0134(02)00649-9","article-title":"Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma","volume":"94","author":"Sun","year":"2003","journal-title":"J Inorg Biochem"},{"issue":"8","key":"10.1016\/j.tranon.2019.02.003_bb0150","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/jnci\/81.8.577","article-title":"New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity","volume":"81","author":"Weislow","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.tranon.2019.02.003_bb0155","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2174\/0929867053764635","article-title":"Metals, toxicity and oxidative stress","volume":"12","author":"Valko","year":"2005","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.tranon.2019.02.003_bb0160","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0006-2952(91)90533-B","article-title":"The role of metallothionein in the reduction of cisplatin-induced nephrotoxicity by Bi3(+)-pretreatment in the rat in vivo and in vitro. Are antioxidant properties of metallothionein more relevant than platinum binding","volume":"41","author":"Boogaard","year":"1991","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.tranon.2019.02.003_bb0165","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1146\/annurev.bi.55.070186.004405","article-title":"Metallothionein","volume":"55","author":"Hamer","year":"1986","journal-title":"Annu Rev Biochem"},{"issue":"10","key":"10.1016\/j.tranon.2019.02.003_bb0170","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1074\/jbc.270.10.5506","article-title":"Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes","volume":"270","author":"Lazo","year":"1995","journal-title":"J Biol Chem"},{"issue":"22","key":"10.1016\/j.tranon.2019.02.003_bb0175","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1016\/S0021-9258(18)67521-0","article-title":"The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation","volume":"261","author":"Braughler","year":"1986","journal-title":"J Biol Chem"},{"issue":"Pt 5","key":"10.1016\/j.tranon.2019.02.003_bb0180","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0351147","article-title":"Biochemistry of oxidative stress","volume":"35","author":"Halliwell","year":"2007","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"10.1016\/j.tranon.2019.02.003_bb0185","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000356808","article-title":"Carvedilol protects against iron-induced microparticle generation and apoptosis of endothelial cells","volume":"132","author":"Chan","year":"2014","journal-title":"Acta Haematol"},{"issue":"5","key":"10.1016\/j.tranon.2019.02.003_bb0190","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1159\/000430173","article-title":"Thrombopoietin Protects Cardiomyocytes from Iron-Overload Induced Oxidative Stress and Mitochondrial Injury","volume":"36","author":"Chan","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.tranon.2019.02.003_bb0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.taap.2017.11.005","article-title":"Deferiprone inhibits iron overload-induced tissue factor bearing endothelial microparticle generation by inhibition oxidative stress induced mitochondrial injury, and apoptosis","volume":"338","author":"Chan","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"issue":"26","key":"10.1016\/j.tranon.2019.02.003_bb0200","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1021\/bi00374a003","article-title":"Iron(II)-substituted metallothionein: evidence for the existence of iron-thiolate clusters","volume":"25","author":"Good","year":"1986","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.tranon.2019.02.003_bb0205","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/bj2560475","article-title":"V79 Chinese-hamster cells rendered resistant to high cadmium concentration also become resistant to oxidative stress","volume":"256","author":"Mello-Filho","year":"1988","journal-title":"Biochem J"},{"issue":"1-2","key":"10.1016\/j.tranon.2019.02.003_bb0210","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1023\/A:1006889427520","article-title":"Protection by ebselen against cisplatin-induced nephrotoxicity: antioxidant system","volume":"178","author":"Husain","year":"1998","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.tranon.2019.02.003_bb0215","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/toxsci\/63.2.196","article-title":"Assessment of cisplatin-induced nephrotoxicity by microarray technology","volume":"63","author":"Huang","year":"2001","journal-title":"Toxicol Sci"},{"issue":"1-2","key":"10.1016\/j.tranon.2019.02.003_bb0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/03602539709037585","article-title":"Metallothionein in physiological and physiopathological processes","volume":"29","author":"Moffatt","year":"1997","journal-title":"Drug Metab Rev"},{"issue":"3","key":"10.1016\/j.tranon.2019.02.003_bb0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1523-5378.2000.00027.x","article-title":"Double-blind comparison of absorbable colloidal bismuth subcitrate and nonabsorbable bismuth subnitrate in the eradication of Helicobacter pylori and the relief of nonulcer dyspepsia","volume":"5","author":"Whitehead","year":"2000","journal-title":"Helicobacter"},{"issue":"6","key":"10.1016\/j.tranon.2019.02.003_bb0230","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12185-013-1348-2","article-title":"Treatment of gastric MALT lymphoma with a focus on Helicobacter pylori eradication","volume":"97","author":"Guo","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.tranon.2019.02.003_bb0235","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-015-0196-3","article-title":"Genetically modified \"obligate\" anaerobic Salmonella typhimurium as a therapeutic strategy for neuroblastoma","volume":"8","author":"Guo","year":"2015","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.tranon.2019.02.003_bb0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13045-016-0330-x","article-title":"The novel thiosemicarbazone, di-2-pyridylketone 4-cyclohexyl-4-methyl-3-thiosemicarbazone (DpC), inhibits neuroblastoma growth in vitro and in vivo via multiple mechanisms","volume":"9","author":"Guo","year":"2016","journal-title":"J Hematol Oncol"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523318302183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523318302183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T14:35:32Z","timestamp":1761834932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523318302183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1936523318302183"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2019.02.003","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}